EHR

U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade

Ingelheim, Germany/Ridgefield, Connecticut, U.S. Idiopathic pulmonary fibrosis (IPF) is a progressive disease, causing a continuous decline in lung function.1Approval is...

Verisma Recognized by Industry Clients as Top Release of Information Solution in Black Book’s 2026 Survey, Extending Market Leadership Into Seventh Consecutive Year

IoT in Healthcare Market to Surpass USD 594.5 Billion by 2035 — AI & Smart Devices Power the Next Wave of Digital Health: Vantage Market Research

NEW YORK, Oct. 7, 2025 /PRNewswire/ -- The Global IoT in Healthcare Market is projected to expand from USD 56.7...

Century Health and Balboa Nephrology Partner to Unlock AI-Driven Insights for Clinical Research and Drug Development in Chronic Kidney Diseases

Chronic kidney disease affects more than 35 million Americans, with progression that varies greatly across patients, making diagnosis and treatment...

2026 State of Release of Information Technology Report Reveals Market Consolidation, AI Integration, and Escalating Compliance Risks

New research from Black Book benchmarks U.S. healthcare's ROI technology landscape - complimentary report now available to providers and payers....

error: Content is protected !!